In colorectal, hepatocellular and lung cancer, SESN2 is characterized as a tumor suppressor because of its decreased expression, which is associated with advanced tumor stage, metastasis and poor survival of cancer patients [17,18,19]. Here, SESN2 is linked to lung cancer.